BioPharma Dive ٦ مارس ٢٠٢٦ Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
BioPharma Dive ٤ مارس ٢٠٢٦ FDA again targets GLP-1 compounders; Intellia to restart heart disease trial